ID   PaCaDD-183
AC   CVCL_M468
SY   PACADD-183
DR   cancercelllines; CVCL_M468
DR   Cell_Model_Passport; SIDM01327
DR   DSMZ; ACC-751
DR   DSMZCellDive; ACC-751
DR   Wikidata; Q54937429
RX   CelloPub=CLPUB00002;
CC   Population: Caucasian.
CC   Doubling time: 43.3 hours (CelloPub=CLPUB00002); ~2-3 days (DSMZ=ACC-751).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (CelloPub=CLPUB00002).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-751
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 28
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,13
ST   FGA: 24,25
ST   Penta D: 9,13
ST   Penta E: 10,11
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 16
//
RX   CelloPub=CLPUB00002;
RA   Ruckert F., Werner K., Aust D., Hering S., Saeger H.-D.,
RA   Grutzmann R., Pilarsky C.;
RT   "Establishment and characterization of six primary pancreatic cancer
RT   cell lines.";
RL   Austin J. Cancer Clin. Res. 2:1055.01-1055.05(2015).
//